Deal Announcements

Rules Based Medicine Captures $25 Million First Round

Tuesday, October 16, 2007 5:00:00 AM PDT | VentureDeal Staff

AUSTIN, TX -- Biotech diagnostic company Rules Based Medicine, Inc. said that it closed its first institutional round of financing, securing $25 million in new investment.

RBM provides a complete line of protein biomarker testing products and services.  It enables pre-clinical and clinical researchers to to generate immunoassay data for hundreds of proteins in a more cost effective manner.

Equity Group Investments, LLC led the round, which included Cross Creek Capital and the Stephens Group.  The company will use the proceeds to pay off debt, validate additional biomarkers for medical diagnostics and potentially acquire or invest in related technologies.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1